Compass Therapeutics, Inc. Common Stock
A$3.171
AUD
Last updated on --.
24h volume6.45M
24h highest3.3957 AUD
24h lowest2.9980 AUD
24h Price movement+2.96%
CMPX recent prices
24 Hours
+2.96%+A$0.09102
30 days
+25.82%+A$0.66514
60 days
-54.61%-A$3.900
90 days
-59.03%-A$4.671
Key data
Previous close3.0807 AUD
Market cap476.61M AUD
Volume6.45M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.53211 AUD
Net income (FY)-95.46M AUD
Revenue (FY)--
Last report date5 May 2026
About Compass Therapeutics, Inc. Common Stock
HeadquartersBOSTON
Employees (FY)39.00
Net income per employee (FY)-2.45M AUD
Listed onNasdaq
CMPX conversion tables
 |  |
|---|---|
| 0.5 CMPX | 1.585 AUD |
| 1 CMPX | 3.171 AUD |
| 5 CMPX | 15.85 AUD |
| 10 CMPX | 31.71 AUD |
| |
|---|---|
| 0.5 AUD | 0.15765 CMPX |
| 1 AUD | 0.31529 CMPX |
| 5 AUD | 1.576 CMPX |
| 10 AUD | 3.152 CMPX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CMPX is trading at A$3.171, +2.96% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CMPX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CMPX is currently trading at A$3.171, +2.96% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CMPX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CMPX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CMPX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CMPX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Compass Therapeutics, Inc. Common Stock's market cap is currently 476.61M AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume6.45M
24h highest3.3957 AUD
24h lowest2.9980 AUD
24h Price movement+2.96%
Start trade with CMPX Perpetual
Sign up to trade